HY26 Results - Media Release

Open PDF
Stock Medibank Private Ltd (MPL.ASX)
Release Time 19 Feb 2026, 7:39 a.m.
Price Sensitive Yes
 Medibank Private Ltd Reports Strong HY26 Results
Key Points
  • Net resident policyholder growth of 38,300, up 1.9% over 12 months
  • Medibank Health segment profit up 28.5% to $48.3m
  • Interim dividend of 8.3 cents per share, up 6.4% from previous year
Full Summary

Medibank Private Ltd has reported strong half-year results for FY26, with net resident policyholder growth of 38,300 (up 1.9% over 12 months) and a 28.5% increase in Medibank Health segment profit to $48.3 million. The company's health insurance business saw a 3.5% increase in operating profit, while net investment income decreased by 17.1% due to lower average RBA cash rates. Underlying net profit after tax was down 0.3% to $297.8 million. The Board has determined a fully franked interim ordinary dividend of 8.3 cents per share, up 6.4% from the previous year. Medibank is on track to achieve its 2030 aspiration of engaging with around 10 million people in their health and wellbeing, with 55% of resident policyholders now engaging with its health and wellbeing services. The company's Amplar Health business delivered a total of 2.3 million patient interactions across both public and private systems during the half. Medibank has also finalized the acquisition of Better Medical, establishing one of the largest primary care networks in the country. The company expects resident health insurance policyholder growth and Medibank Health organic operating profit growth to continue in FY26.

Guidance

Resident health insurance: Aim to grow market share in a disciplined way, including further volume growth in the Medibank brand. Industry growth expected to moderate relative to FY25. Claims growth per policy unit expected to be 2.6% - 2.9%. Mediabank Health: FY26 organic operating profit growth expected to be similar to 1H26, plus a c. $6m contribution from Better Medical in 2H26.

Outlook

Medibank remains a strong and growing health company with a clear vision for the future. The company will continue to drive the health transition through its investments, partnerships, and record of innovation, delivering greater value, choice, and control in health for its customers and the broader health system.